Edwards Lifesciences rises after co raises 2025 sales forecast

Shares of medical device maker Edwards Lifesciences EW.N rise 4.3% to $73.50 premarket

Company late on Wednesday raised its 2025 sales forecast to a range of $5.7 billion to $6.1 billion, from between $5.6 billion and $6 billion earlier

Edwards expects a tariff impact of 5 cents per share for 2025, with a larger hit expected in 2026

Company posted Q1 adj. profit of 64 cents per share, beating analysts' estimates of 60 cents per share, according to data compiled by LSEG

Co also reaffirmed its 2025 adjusted profit of $2.40 to $2.50 per share

As of last close, EW has fallen 4.8% YTD